{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:02:20Z","timestamp":1772460140092,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178606","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:44:38Z","timestamp":1769618678000},"page":"178606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacological activity of a new ligand binding at the histamine site of the NMDA receptor in rodents"],"prefix":"10.1016","volume":"1016","author":[{"given":"Aude","family":"Burban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Faucard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5759-3919","authenticated-orcid":false,"given":"Vincent","family":"Armand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejphar.2026.178606_bib1","first-page":"1","article-title":"The molecules lost; new compounds binding at the histamine site of the NMDA receptor (NMDA(HA)R)","volume":"7","author":"Armand","year":"2024","journal-title":"Adv Neur Neur Sci"},{"key":"10.1016\/j.ejphar.2026.178606_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.8391168","article-title":"Enhancement by histamine of NMDA-mediated synaptic transmission in the hippocampus","volume":"261","author":"Bekkers","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.178606_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.ejphar.2026.178606_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.2007.164.5.705","article-title":"Endophenotyping schizophrenia","volume":"164","author":"Braff","year":"2007","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejphar.2026.178606_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00213-003-1635-3","article-title":"Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice","volume":"172","author":"Brody","year":"2004","journal-title":"Psychopharmacology (Berl)."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178606_bib6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1124\/jpet.109.158543","article-title":"Histamine potentiates N-Methyl-D-Aspartate receptors by interacting with an allosteric site distinct from the polyamine-binding site","volume":"332","author":"Burban","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178606_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1048463","article-title":"Neurobehavioral differences of valproate and risperidone on MK-801 inducing acute hyperlocomotion in mice","volume":"2022","author":"Chen","year":"2022","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.ejphar.2026.178606_bib8","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1111\/bph.13919","article-title":"Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research","volume":"174","author":"Dauvermann","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178606_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178606_bib10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1471-4159.2006.04002.x","article-title":"N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain","volume":"98","author":"Faucard","year":"2006","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178606_bib11","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1471-4159.1989.tb09237.x","article-title":"Sensitive radioimmunoassays for histamine and tele-methylhistamine in the brain","volume":"53","author":"Garbarg","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.178606_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.ejphar.2026.178606_bib13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.neuropharm.2011.03.015","article-title":"NMDA receptors, cognition and schizophrenia\u2013testing the validity of the NMDA receptor hypofunction hypothesis","volume":"62","author":"Gilmour","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178606_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41386-023-01614-3","article-title":"Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry","volume":"49","author":"Hanson","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178606_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbr.2014.06.012","article-title":"Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus)","volume":"271","author":"Hoffman","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2026.178606_bib16","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00213-023-06454-z","article-title":"MK-801 and cognitive functions: investigating the behavioral effects of a non-competitive NMDA receptor antagonist","volume":"240","author":"Janus","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178606_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40501-014-0010-9","article-title":"Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia","volume":"1","author":"Javitt","year":"2015","journal-title":"Curr. Treat Options Psychiatr."},{"key":"10.1016\/j.ejphar.2026.178606_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-pharmtox-051921-093250","article-title":"Cognitive impairment associated with schizophrenia: from pathophysiology to treatment","volume":"63","author":"Javitt","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.178606_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178606_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuropharm.2017.09.014","article-title":"Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenialike behaviors in mice","volume":"126","author":"Jeon","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.178606_bib21","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s00213-014-3481-x","article-title":"CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice","volume":"231","author":"Khella","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2026.178606_bib22","series-title":"Investigations of Early Nutrition Effects on Long-Term Health","article-title":"Hyperlocomotion test for assessing behavioral disorders","volume":"1735","author":"Ma","year":"2017"},{"key":"10.1016\/j.ejphar.2026.178606_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0091-3057(01)00561-5","article-title":"Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone","volume":"69","author":"Mansbach","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178606_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/jpet.116.238634","article-title":"Effects of repeated ropinirole treatment on phencyclidine-induced hyperlocomotion, prepulse inhibition deficits, and social avoidance in rats","volume":"361","author":"Maple","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178606_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0014-2999(97)01188-6","article-title":"MK-801-induced hyperlocomotion : differential effects of M100907, SDZ PSD 958 and raclopride","volume":"335","author":"Martin","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178606_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","article-title":"Mice with reduced NMDA receptor expression display behaviors related to schizophrenia","volume":"98","author":"Mohn","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178606_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1570159X14666160321122703","article-title":"The development of rapastinel (formerly GLYX-13); A rapid acting and long lasting antidepressant","volume":"15","author":"Moskal","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2026.178606_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-2999(00)00263-6","article-title":"Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro","volume":"397","author":"Murray","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178606_bib29","article-title":"Synthese und Pharmakologie von neuen potenten Liganden der Histamin-Bindungsstelle des NMDA-Rezeptors","author":"Nuss","year":"2001","journal-title":"Deutsche Pharmazeutische Gesellschaft: Landesgruppe Berlin-Brandenburg. Der wissenschaftliche Nachwuchs stellt sich vor. Berlin (12. Juli 2001), Abstractbuch"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178606_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.npp.1380103","article-title":"Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated","volume":"11","author":"\u00d6gren","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178606_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/0269881116672098","article-title":"Swertisin ameliorates pre-pulse inhibition deficits and cognitive impairment induced by MK-801 in mice","volume":"31","author":"Oh","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178606_bib32","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/biom14091128","article-title":"Dysfunction of the NMDA receptor in the pathophysiology of schizophrenia and\/or the pathomechanisms of treatment-resistant schizophrenia","volume":"14","author":"Okubo","year":"2024","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178606_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF02253532","article-title":"Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats","volume":"111","author":"Ouagazzal","year":"1993","journal-title":"Psychopharmacology (Berl)."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178606_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coph.2006.08.011","article-title":"NMDA receptor subunits: function and pharmacology","volume":"7","author":"Paoletti","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178606_bib35","first-page":"114","article-title":"Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans","volume":"2","author":"Prell","year":"1988","journal-title":"Compr Gerontol. [A]"},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2026.178606_bib36","first-page":"161","article-title":"Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL\/6 mice","volume":"580","author":"Qi","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"7702","key":"10.1016\/j.ejphar.2026.178606_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41586-018-0039-9","article-title":"Mechanism of NMDA receptor channel block by MK-801 and memantine","volume":"556","author":"Song","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ejphar.2026.178606_bib38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/FBP.0b013e328358590d","article-title":"Drug\u2013drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophrenia","volume":"23","author":"Sparkman","year":"2012","journal-title":"Behav. Pharmacol."},{"issue":"22","key":"10.1016\/j.ejphar.2026.178606_bib39","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1073\/pnas.0402662101","article-title":"Gene knockout of glycine transporter 1: characterization of the behavioral phenotype","volume":"101","author":"Tsai","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2026.178606_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2004.05.005","article-title":"Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis","volume":"72","author":"Tuominen","year":"2005","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.ejphar.2026.178606_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40263-022-00935-z","article-title":"Progress and pitfalls in developing agents to treat neurocognitive deficits associated with schizophrenia","volume":"36","author":"Veselinovi\u0107","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2026.178606_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0896-6273(93)90113-6","article-title":"Histamine potentiates N-methyl-D-aspartate responses in acutely isolated hippocampal neurons","volume":"11","author":"Vorobjev","year":"1993","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178606_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/138161210790170085","article-title":"Conditioned avoidance response in the development of new antipsychotics","volume":"16","author":"Wadenberg","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178606_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-3565(25)28847-4","article-title":"Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. II. Competitive antagonists","volume":"177","author":"Waud","year":"1971","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178606_bib45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0026-895X(25)09731-7","article-title":"Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine","volume":"46","author":"Williams","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178606_bib46","first-page":"5","article-title":"An overview of animal models related to schizophrenia can J psychiatry","volume":"64","author":"Winship","year":"2019"},{"issue":"13","key":"10.1016\/j.ejphar.2026.178606_bib47","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1097\/00001756-199609020-00030","article-title":"Histamine slows the onset of desensitization of rat cortical NMDA receptors","volume":"7","author":"Zwart","year":"1996","journal-title":"Neuroreport"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:07:29Z","timestamp":1772456849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S0014299926000889"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178606","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological activity of a new ligand binding at the histamine site of the NMDA receptor in rodents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178606"}}